Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1)

计划入组 4,479 人 · 首次发布于 2019 年 9 月 12 日

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2)

计划入组 238 人 · 首次发布于 2019 年 10 月 7 日

A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years

计划入组 17,797 人 · 首次发布于 2021 年 5 月 24 日

JNJ-78901563

Escherichia coli

Escherichia coli strain Nissle 1917

BAO PHARMA-B

Oncolytics Biotech

Canada

Theriva Biologics

United States

CARB-X Awards $1.1 Million to Phiogen for Novel Bacteriophage Treatment Against Drug-Resistant E. coli Bloodstream Infections

Sanofi and J&J Join Forces in $175M Deal to Combat E. coli Sepsis with Novel Vaccine

SNIPR Biome Doses First Patient with CRISPR-Armed Phage Therapy SNIPR001 for Drug-Resistant E. coli Prevention